Business Segments · Cost of precision oncology testing
Business Segments — Cost of precision oncology testing
Guardant Health Business Segments — Cost of precision oncology testing remained flat by 0.0% to $84.30M in Q4 2025 compared to the prior quarter. Year-over-year, this metric grew by 20.7%, from $69.86M to $84.30M. Over 3 years (FY 2022 to FY 2025), Business Segments — Cost of precision oncology testing shows an upward trend with a 33.5% CAGR. This is a positive signal — lower values indicate better performance for this metric.
Analysis
StatementSegment
CategoryEfficiency
SignalLower is better
VolatilityStable
First reportedQ1 2022
Last reportedQ4 2025Feb 19, 2026
How to read this metric
A decrease in this cost relative to testing volume indicates improved lab efficiency and economies of scale.
Detailed definition
This represents the specific direct costs attributable to the laboratory processing and clinical reporting of precision...
Peer comparison
Direct cost of services for specialized diagnostic or clinical laboratory providers.
Metric ID:
gh_segment_reportable_segment_cost_of_precision_oncology_testingHistorical Data
4 years
| FY'22 | FY'23 | FY'24 | FY'25 | |
|---|---|---|---|---|
| Value | $141.69M | $219.07M | $279.44M | $337.20M |
| YoY Change | — | +54.6% | +27.6% | +20.7% |
Range$141.69M – $337.20M
CAGR+33.5%
Avg YoY Growth+34.3%
Median YoY Growth+27.6%
Current Streak3+ years growth
Similar Metrics at Other Companies
Frequently Asked Questions
- What is Guardant Health's business segments — cost of precision oncology testing?
- Guardant Health (GH) reported business segments — cost of precision oncology testing of $84.30M in Q4 2025.
- How has Guardant Health's business segments — cost of precision oncology testing changed year-over-year?
- Guardant Health's business segments — cost of precision oncology testing increased by 20.7% year-over-year, from $69.86M to $84.30M.
- What is the long-term trend for Guardant Health's business segments — cost of precision oncology testing?
- Over 3 years (2022 to 2025), Guardant Health's business segments — cost of precision oncology testing has grown at a 33.5% compound annual growth rate (CAGR), from $141.69M to $337.20M.
- What does business segments — cost of precision oncology testing mean?
- The direct costs of running the company's oncology diagnostic tests.